Literature DB >> 6849371

Effect of verapamil on blood pressure and lesions in heart and kidney of rats made hypertensive by deoxycorticosterone (DOC).

A P Aguas, P A Nickerson.   

Abstract

The effect of verapamil, a calcium antagonist, was studied in rats treated with deoxycorticosterone (DOC). DOC induced hypertensive cardiovascular disease with accompanying gross and microscopic lesions in heart and kidney. Verapamil administered in the drinking fluid (1% sodium chloride) prevented hypertension and significantly ameliorated the incidence and severity of cardiovascular lesions. With exception of the spleen, verapamil did not prevent renal or myocardial hypertrophy in rats treated with DOC in spite of prevention of hypertension. The level of verapamil in the serum of animals consuming verapamil (0.37 +/- 0.16 microgram/ml) was less than that of the DOC-verapamil group (0.89 +/- 0.16 microgram/ml), although the difference was not significant. These results confirm the efficacy of verapamil in reducing blood pressure and in ameliorating vascular lesions.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6849371      PMCID: PMC1916138     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  35 in total

1.  The role of prevention or relief of pressure overload on the myocardial cell of the spontaneously hypertensive rat: a morphometric and stereologic study.

Authors:  R J Tomanek
Journal:  Lab Invest       Date:  1979-01       Impact factor: 5.662

2.  Adrenal plasma levels of corticosterone and deoxycorticosterone in methylandrostenediol-salt induced hypertension (1).

Authors:  P M Hyde; E A Daigneault
Journal:  Steroids       Date:  1968-06       Impact factor: 2.668

3.  Metopirone-induced hypertension in the rat.

Authors:  H D Colby; F R Skelton; A C Brownie
Journal:  Endocrinology       Date:  1970-03       Impact factor: 4.736

4.  [Clinical experimental studies on the blood pressure reducing effect of verapamil].

Authors:  W D Brittinger; A Schwarzbeck; K W Wittenmeier; W D Twittenhoff; B Stegaru; W Huber; R W Ewald; G E von Henning; M Fabricius; M Strauch
Journal:  Dtsch Med Wochenschr       Date:  1970-09-11       Impact factor: 0.628

5.  Deoxycorticosterone production in adrenal regeneration hypertension: in vitro vs. in vivo comparison.

Authors:  J P Rapp
Journal:  Endocrinology       Date:  1969-06       Impact factor: 4.736

6.  Production of hypertensive vascular disease in the rat by methyltestosterone.

Authors:  A Molteni; A C Brownie; F R Skelton
Journal:  Lab Invest       Date:  1969-08       Impact factor: 5.662

7.  Calcium content of arteriolar walls in normotensive and hypertensive rats.

Authors:  L Tobian; G Chesley
Journal:  Proc Soc Exp Biol Med       Date:  1966-02

Review 8.  Verapamil: a review of its pharmacological properties and therapeutic use.

Authors:  B N Singh; G Ellrodt; C T Peter
Journal:  Drugs       Date:  1978-03       Impact factor: 9.546

9.  A study on the effects of nifedipine in hypertensive crises and severe hypertension.

Authors:  I Kuwajima; K Ueda; C Kamata; S Matsushita; K Kuramoto; M Murakami; Y Hada
Journal:  Jpn Heart J       Date:  1978-07

10.  The occurrence of 11-deoxycorticosterone (DOC)-induced hypertension in the Long-Evans rat.

Authors:  A C Brownie; S Gallant; P A Nickerson; L M Joseph
Journal:  Endocr Res Commun       Date:  1978
View more
  3 in total

1.  Prevention of 11-deoxycorticosterone-salt-induced glomerular hypertrophy and glomerulosclerosis by dietary phosphate binder.

Authors:  T Shimamura
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

2.  Anti-proliferative actions of T-type calcium channel inhibition in Thy1 nephritis.

Authors:  Andrea Cove-Smith; Christopher J Mulgrew; Olena Rudyk; Neelanjana Dutt; Linda M McLatchie; Michael J Shattock; Bruce M Hendry
Journal:  Am J Pathol       Date:  2013-06-05       Impact factor: 4.307

3.  Effects of chronic quercetin treatment on antioxidant defence system and oxidative status of deoxycorticosterone acetate-salt-hypertensive rats.

Authors:  Milagros Galisteo; Maria Francisca García-Saura; Rosario Jiménez; Inmaculada Concepción Villar; Antonio Zarzuelo; Félix Vargas; Juan Duarte
Journal:  Mol Cell Biochem       Date:  2004-04       Impact factor: 3.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.